Skip to content

    Coforge Limited

    COFORGE
    Information Technology·23 Jan 2026
    Management Summary

    Coforge delivered a strong Q3 FY26 with 4.4% CC revenue growth and 32.8% YTD dollar growth, fueled by significant large deal wins and robust key account expansion. Despite a QoQ dip in EBIT margins to 13.4% due to wage hikes and hedge losses, the company is on track to meet its 14% FY26 EBIT guidance and anticipates an exceptional FY27. Strategic acquisitions like Encora and a strong focus on AI-led engineering are expected to drive continued industry-leading growth, supported by a healthy order book and strong free cash flow generation.

    Highlights

    5
    • Coforge registered a sequential revenue growth of 4.4% in CC terms for Q3 FY26, contributing to a robust YTD dollar revenue growth of 32.8%.

    • The next 12-month signed order book reached a record $1.72 billion, which is 30% higher than the same period last year, indicating strong future growth visibility.

    • Free cash flow (FCF) for the quarter came in at 110% of normalized PAT, significantly ahead of the sustained guidance of 70% to 80%.

    • LTM attrition for the quarter fell further to 10.9%, positioning Coforge as one of the lowest attrition firms across the industry.

    • The company signed six large deals in the seasonally weak Q3, with 16 large deals closed in the first three quarters of the year, demonstrating strong sales execution.

    Concerns

    3
    • Reported EBIT margin for the quarter stood at 13.4%, down 60 bps QoQ, primarily due to wage hikes (150 bps impact) and increased hedge losses (INR 434 million).

    • Exceptional items amounted to INR 147 crores, including INR 118 crores for the New Labour code, INR 13.5 crores for Encora acquisition expenses, and INR 16.2 crores for cybersecurity legal expenses.

    • The working capital cycle slightly increased to 49 days from 48 days in the previous quarter.

    What Changed1

    vs Q4 FY26

    Risks discussed3 → 4 (+1)
    Key financials

    Metrics

    8

    Periods

    2

    Headline

    7
    • Revenue
      ₹4,188.1 Cr
      QoQ+5.1%
    • Revenue (CC Growth)
      QoQ+4.4%
    • EBIT Margin
      13.4%
      YoY+1.9%QoQ-0.6%
    • Underlying EBIT Margin (ex-hedge losses)
      14.4%
    • EPS (ex-exceptional items)
      ₹10.9

    LTM

    1
    • Attrition
      10.9%

    Order Book

    high confidence

    Total Value

    USD 1.72 billion

    as of 2025-12-31

    quantified
    30.0% YoY

    Inflow this qtr

    USD 593 million

    Execution

    executable over the next 12 months

    Composition

    Large Deals (Q3)(deal size)
    Banking (Q3 Large Deals)(vertical)
    Travel (Q3 Large Deals)(vertical)
    Insurance (Q3 Large Deals)(vertical)
    Healthcare (Q3 Large Deals)(vertical)

    "Q3 saw strong order intake with six large deals signed, contributing to a 30% higher next 12-month order book, setting up robust growth for FY26 and FY27."

    Source:
    Prepared remarks

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    USD 3 million

    Debt

    Debt disclosed

    Maturity: 3 years

    M&A

    Encora

    acquisition · pending regulatory · Consideration ₹NaN (mixed)

    Liquidity

    Liquidity disclosed

    Free cash flow (FCF) for the quarter came in at $45.7 million, resulting in an FCF to normalized PAT of 110%.

    Guidance & targets

    11
    CategoryTargetPriority
    Profitability
    EBIT Margin
    15%
    High
    Profitability
    EBIT Margin
    14%
    High
    Profitability
    EPS Dilution (Combined Business)
    no dilution
    High
    Profitability
    Margin Increase
    further increase
    High
    Cash Flow
    FCF to Normalized PAT
    70% to 80%
    High
    Growth
    Healthcare, Hi-Tech, Public Sector Growth
    on steroids
    Medium
    Growth
    Banking Vertical Growth
    fastest growing core vertical
    Medium
    Growth
    Insurance Vertical Growth
    robust growth
    Medium
    Order Book
    Total Number of Large Deals
    will go up
    Medium
    Operational Efficiency
    Utilization Rate
    sharply increase
    Medium
    Operational Efficiency
    Working Capital Cycle
    closer to 50 days
    High

    Encora Acquisition Closure & Consolidation

    Q4 FY26
    CurrentPending regulatory approvals (HSR expected Feb, all approvals by March-April)
    TargetRegulatory approvals complete, consolidation in Q4

    Why it matters

    Successful closure and consolidation of Encora are key to realizing the strategic benefits and achieving the FY27 EPS non-dilution guidance.

    And I think by March timeframe, we should be able to get pretty much all the approvals between March and April. And that is the time when we will start consolidating in quota as well.

    How to verify

    capital_allocation.m_and_a[target='Encora'].status

    Risks & concerns

    4
    RiskSeverity

    EBIT margin compression due to wage hikes

    Wage hikes had a 150 bps impact on margins in Q3, partially offset by margin initiatives.Management acknowledged

    medium

    Increased hedge losses impacting reported EBIT

    Hedge losses amounted to INR 434 million in Q3, reflecting an adverse impact of 26 bps on reported EBIT and 90 bps on EBIT margins when taken in the top line.Management acknowledged

    medium

    Exceptional items impacting net profit

    INR 147 crores in exceptional items, including New Labour code, Encora acquisition expenses, and cybersecurity legal expenses.Management acknowledged

    low

    Integration and funding expenses for Encora acquisition

    Expected $10-$15 million over the next two quarters for integration and funding expenses related to the Encora acquisition.Management acknowledged

    low

    Q&A highlights

    7

    “Given the large deal momentum we have seen in Q3 and what we think is likely to happen in Q4, we would suspect that while healthcare and high tech will continue to grow at a tear, banking might be the fastest growing core vertical of the firm next year. ... We expect robust growth in insurance in FY2026 which is almost done. Very robust, possibly higher growth in FY2027 than what we registered even in FY2026.”

    Clarifies management's confidence in the growth trajectory of BFS and Insurance, despite perceived softness, and highlights new high-growth verticals.

    asked by Abhishek Pathak

    3 min read6 chapters

    Detailed Narrative

    01

    Robust Revenue Growth and Strong Outlook

    Coforge reported a sequential revenue growth of 4.4% in constant currency (CC) terms for Q3 FY26, contributing to an impressive year-to-date (YTD) dollar revenue growth of 32.8%. This performance was underpinned by strong large deal velocity, with six large deals signed in the seasonally weak quarter. Management expressed confidence in achieving a very successful FY26 and an exceptional FY27, citing a next 12-month signed order book that is 30% higher year-on-year, standing at $1.72 billion.

    02

    EBIT Margin Dynamics and Cost Management

    The reported EBIT margin for Q3 FY26 was 13.4%, a 60 basis points (bps) sequential decline, primarily due to wage hikes which impacted margins by 150 bps. However, this was partially offset by ongoing margin initiatives and lower ESOP costs. Excluding hedge losses, the underlying EBIT for the firm was 14.4%. The company aims to register a 15% EBIT in Q4, which would lead to meeting its 14% EBIT guidance for the full FY26, demonstrating effective cost management despite inflationary pressures.

    03

    Strategic Acquisitions and AI-Led Transformation

    The acquisition of Encora is highlighted as a defining moment, establishing a scaled AI-led engineering, data services, and cloud services capability. This is expected to accelerate Coforge's industry-leading growth. The firm is finalizing a $550 million, 3-year term loan for Encora, with regulatory approvals anticipated by March-April 2026, ensuring no EPS dilution in FY27 for the combined entity. Coforge is actively infusing AI into every engagement, moving towards hybrid delivery models and outcome-based commercial structures, with platforms like ForgeX and CodeInsightAI deployed across 54 clients.

    04

    Strong Order Intake and Vertical Performance

    Q3 FY26 saw a total order intake of $593 million, nearly reaching the $600 million mark. The company's top 5 and top 10 clients grew by 51% and 47% YTD respectively in dollar terms, contributing 21.0% and 30.7% to Q3 revenue. Verticals like Healthcare and Hi-Tech, contributing 10.5% of total revenue, nearly doubled year-on-year. Banking is expected to be the fastest-growing core vertical next year, while Travel and Insurance are also projected for robust growth, with Banking and Travel expected to outpace Insurance.

    05

    Cash Flow Generation and Working Capital Efficiency

    Coforge demonstrated strong cash flow generation, with Free Cash Flow (FCF) for the quarter reaching $45.7 million. This translated to an FCF to normalized PAT ratio of 110%, significantly exceeding the company's sustained guidance of 70% to 80%. The working capital cycle remained efficient at 49 days, a slight increase from 48 days in the previous quarter, with billed DSO at 67 days, unbilled at 28 days, and contract assets at 14 days.

    06

    People and Utilization

    The total headcount at the end of Q3 stood at 35,341, with a net addition of 445 people during the quarter. Utilization was 81.8% and is expected to sharply increase in Q4. The company maintained one of the lowest attrition rates in the industry, with LTM attrition falling further to 10.9%. Management noted that headcount growth lagging revenue growth is partly due to outcome-based contracts and strategic induction of freshers, which helps manage the average revenue per employee (ARC).

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.